Prognostic value of PIK3CA gene assessment in tissue & plasma in metastatic colorectal cancer (mCRC)

被引：0

作者：

Brage, E. Teran ^{[1
]}

Tocino, R. Vidal ^{[1
]}

Puertas, P. Reguera ^{[1
]}

Mateos, Y. Lopez ^{[1
]}

Gutierrez, A. Lopez ^{[1
]}

Hernandez, M. M. Abad ^{[2
]}

Manzano, J. Sayagues ^{[2
]}

Rodrigues, A. ^{[1
]}

Montero-Gonzalez, J. ^{[2
]}

Araujo, D. Morchon ^{[1
]}

Gonzalez, J. C. Redondo ^{[1
]}

Mejorada, R. Lozano ^{[1
]}

Sanchez, E. Fonseca ^{[1
]}

机构：

[1] Univ Hosp Salamanca, Med Oncol Dept, Salamanca, Spain

[2] Univ Hosp Salamanca, Dept Pathol, Salamanca, Spain

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.05.116

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

105P

引用

页码：S49 / S49

页数：1

共 50 条

[41] Mutation profiling of KRAS, BRAF, and PIK3CA genes in colorectal cancer tissue.
McKeown, S.
Doherty, J. E.
Beaney, M. P.
Latten, M. J.
Murray, H. A.
Crockard, M. A.
Lamont, J. V.
FitzGerald, S. P.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[42] Comparison of PIK3CA gene status between primary tumors and paired metastases in metastatic or recurrent colorectal cancer.
Ying, Jieer
He, Qiong
Xu, Qi
Liu, Bixia
Wu, Wei
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[43] Comparison of KRAS and PIK3CA gene status between primary tumours and paired metastases in metastatic or recurrent colorectal cancer
Ying, J. E.
He, Q.
Sun, W. Y.
Xu, Q.
Li, D. C.
Liu, B. X.
Du, Y. A.
Cao, W. M.
Chen, L. Y.
Wu, W.
Chen, L.
Luo, C.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S386 - S386
[44] Mutation of the PIK3CA gene in anaplastic thyroid cancer
García-Rostán, G
Costa, AM
Pereira-Castro, I
Salvatore, G
Hernandez, R
Hermsem, MJA
Herrero, A
Fusco, A
Cameselle-Teijeiro, J
Santoro, M
CANCER RESEARCH, 2005, 65 (22) : 10199 - 10207
[45] PIK3CA mutations in Tunisian patients with metastatic colorectal cancer: Patient stratification for targeted therapies
Jaballah-Gabteni, A.
Tounsi, H. Guettiti
Ben Ayed, I.
Yaiche, H.
Ben Jemii, N.
Wider, D.
Boubaker, S.
ANNALS OF ONCOLOGY, 2022, 33 : S350 - S350
[46] The PIK3CA Gene as a Mutated Target for Cancer Therapy
Gustin, John P.
Cosgrove, David P.
Park, Ben Ho
CURRENT CANCER DRUG TARGETS, 2008, 8 (08) : 733 - 740
[47] PIK3CA mutation and methylation influences the outcome of colorectal cancer
Iida, Satoru
Kato, Shunsuke
Ishiguro, Megumi
Matsuyama, Takatoshi
Ishikawa, Toshiaki
Kobayashi, Hirotoshi
Higuchi, Tetsuro
Uetake, Hiroyuki
Enomoto, Masayuki
Sugihara, Kenichi
ONCOLOGY LETTERS, 2012, 3 (03) : 565 - 570
[48] Mutation of the PIK3CA gene in ovarian and breast cancer
Campbell, IG
Russell, SE
Choong, DYH
Montgomery, KG
Ciavarella, ML
Hooi, CSF
Cristiano, BE
Pearson, RB
Phillips, WA
CANCER RESEARCH, 2004, 64 (21) : 7678 - 7681
[49] KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
De Roock, Wendy
De Vriendt, Veerle
Normanno, Nicola
Ciardiello, Fortunato
Tejpar, Sabine
LANCET ONCOLOGY, 2011, 12 (06): : 594 - 603
[50] Prognostic impact of PIK3CA mutations in patients with right-sided colorectal cancer.
Miyasaka, Toshimitsu
Yamada, Takeshi
Sonoda, Hiromichi
Shinji, Seiichi
Matsuda, Akihisa
Ohta, Ryo
Takeda, Kohki
Ueda, Koji
Yoshida, Hiroshi
CANCER SCIENCE, 2022, 113 : 456 - 456

← 1 2 3 4 5 →